|
Abnova is giving a presentation at Innovative Medical Development Summit in Taipei, Taiwan
Venue: Activity Center, National Yang-Ming University Dates: 2 October, 2015 Time: 14:00-14:30 Speaker: Wilber Huang, MD, President & CEO, Abnova Topic: Microfluidic Capture, Identification, and Isolation of EMT-transformed Cancer Stem Cells |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)